ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,197.62
0.39%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Sio Gene Therapies Inc (SIOX)

  7. Sio Gene Therapies Inc (SIOX) ニュース

SIOX

Sio Gene Therapies (SIOX)

Sio Gene Therapies Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SIOX
日付受信時刻ニュースソース見出しコード企業名
2024/02/0221 : 00GlobeNewswire Inc.Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per ShareNASDAQ:SIOXSio Gene Therapies Inc
2023/04/2605 : 05Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:SIOXSio Gene Therapies Inc
2023/04/1805 : 17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SIOXSio Gene Therapies Inc
2023/04/1805 : 14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SIOXSio Gene Therapies Inc
2023/04/1221 : 52Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SIOXSio Gene Therapies Inc
2023/04/0705 : 08Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:SIOXSio Gene Therapies Inc
2023/04/0705 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SIOXSio Gene Therapies Inc
2023/03/1719 : 03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SIOXSio Gene Therapies Inc
2023/03/1605 : 26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SIOXSio Gene Therapies Inc
2023/02/2206 : 06Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SIOXSio Gene Therapies Inc
2023/02/1421 : 04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SIOXSio Gene Therapies Inc
2023/02/1421 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SIOXSio Gene Therapies Inc
2023/02/1421 : 00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
2023/02/1420 : 47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SIOXSio Gene Therapies Inc
2023/02/1322 : 53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SIOXSio Gene Therapies Inc
2023/02/1106 : 01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SIOXSio Gene Therapies Inc
2023/02/0920 : 01Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:SIOXSio Gene Therapies Inc
2022/12/1506 : 49GlobeNewswire Inc.Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and DissolutionNASDAQ:SIOXSio Gene Therapies Inc
2022/12/1506 : 11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SIOXSio Gene Therapies Inc
2022/12/1506 : 05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SIOXSio Gene Therapies Inc
2022/11/1021 : 04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SIOXSio Gene Therapies Inc
2022/11/1021 : 03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SIOXSio Gene Therapies Inc
2022/11/1021 : 00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
2022/09/1505 : 09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SIOXSio Gene Therapies Inc
2022/08/1120 : 04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SIOXSio Gene Therapies Inc
2022/08/1120 : 00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
2022/06/1420 : 02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SIOXSio Gene Therapies Inc
2022/06/1420 : 00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
2022/04/2822 : 05TipRanksAnalyst Explains Why They Downgraded Their Rating on Sio Gene Therapies (SIOX)NASDAQ:SIOXSio Gene Therapies Inc
2022/04/2805 : 25GlobeNewswire Inc.Sio Gene Therapies Provides Corporate UpdateNASDAQ:SIOXSio Gene Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:SIOX

最近閲覧した銘柄

COIN
LBRUSD
LBR [Lybra Finance]
HITB
DRPUBTC
DRP Utility
USOTC
LSTDF
Listed Index Fund Nikkei... (GM)
BOV
HBRE3R
HBR Realty Empreendiment... ON
NASDAQ
OLITU
OmniLit Acquisition
COIN
PLATUSD
BitGuild Platinum
AMEX
UGE
ProShares Ultra Consumer...
EU
3358T
3358T
EU
IUKSR
UBS UKSR INAV
NASDAQ
WYOI
Wyoming Oil Minerals
TSXV
PDVN.P
Pardus Ventures
BIT
XSOE
Wisdomtree Emer Exstateo...
NASDAQ
GPIQ
Goldman Sachs Nasdaq 100...
NASDAQ
SUPN
Supernus Pharmaceuticals
COIN
BOXYBTC
ASX
MYRBOR
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有